- This topic has 0 replies, 1 voice, and was last updated 1 year, 3 months ago by
.
EMA provides recommendations on compassionate use of remdesivir
On April 3, 2020, the EMA provided recommendations on compassionate use of remdesivir for COVID-19 patients who are not eligible for inclusion in clinical trials.
https://www.ema.europa.eu/en/news/ema-provides-recommendations-compassionate-use-remdesivir-covid-19
- You must be logged in to reply to this topic.